Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-553,215.74
% of Total Estimate Gain
-53.66%

Ridgeback Capital Investments L.P.'s Pyxis Oncology Inc Holding Summary

As of 2025-03-31, Ridgeback Capital Investments L.P. held - shares of Pyxis Oncology Inc(PYXS), totaling N/A. This investment constitutes 0% of their stock portfolio, and Ridgeback Capital Investments L.P. now holds 0% of the outstanding Pyxis Oncology Inc(PYXS) stock.

The initial trade took place in 2024Q4. And since then Ridgeback Capital Investments L.P. has made 1 purchases of PYXS, at an average price of $2.87, for a total of 359,231.00 shares. In addition, there have been 1 sales at an average price of $1.33 for 359,231.00 shares. Based on historical transaction data and PYXS's current price of $1.13, Ridgeback Capital Investments L.P.'s estimated gain on his PYXS holdings is $-553,215.74, reflecting a -53.66% gain to date.

Ridgeback Capital Investments L.P. PYXS ($1.13) Holding Chart

Ridgeback Capital Investments L.P. PYXS ($1.13) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1